FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 156 of 156

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
VYNE Nasdaq VYNE Therapeutics Inc. 2834
WHWK Nasdaq Whitehawk Therapeutics, Inc. 2834
XBIO Nasdaq Xenetic Biosciences, Inc. 2834
XERS Nasdaq Xeris Biopharma Holdings, Inc. 2834
XFOR Nasdaq X4 Pharmaceuticals, Inc. 2834
ZYME Nasdaq Zymeworks Inc. 2834
Results 150 through 156 of 156